OTLC Insider Trading - Oncotelic Therapeutics, Inc.

已發行股份	443,477,729 shares
內部人士股份	142,030,646 shares
內部持股	32.03 %
所有內部人士	30

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

0 ( )

8020 out of 10916

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

0.000% ( )

7880 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Oncotelic Therapeutics, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
David Chaplin Director - [D]	1,006	1,006
Joel Tomas Citron	25,000
Richard Chin Director - [D]	40,000	40,000
Frederick W Driscoll Director - [D]	0	0
David Diamond	451,467
Tamar D Howson Director - [D]	8,761	8,761
Chao Hsiao 10% Owner - [10%]	5,974,152	5,974,152
Larn Hwang 10% Owner - [10%]	8,191,162	8,191,162
David Louis Johnson	0
Mark Kessel Director, 10% Owner - [D] [10%]	5,835,241	5,835,241

內部人士	持股數量	分拆調整
Steven W King Director - [D]	3,330,647	3,330,647
Arthur B Laffer	10,000
Peter Langecker Chief Executive Officer, Director - [D] [O]	77,993	77,993
Matthew M Loar Chief Financial Officer - [O]	300,000	300,000
Anthony E Iii Maida CHIEF CLINICAL OFFICER, Director - [D] [O]	1,137,314	1,137,314
Gerald PhD McMahon Director - [D]	18,611	18,611
Chulho Park CHIEF TECHNOLOGY OFFICER - [O]	2,833,992	2,833,992
Simon Pedder	258,171
Barbara Riching	150,000
Donald Rogers Reynolds Director - [D]	280,000	280,000

內部人士	持股數量	分拆調整
Bobby W Phd Sandage	258,171
William N Shiebler	10,000
Per Olof Soderberg Director - [D]	179,256	179,256
Saran Saund CHIEF BUSINESS OFFICER - [O]	16,457,480	16,457,480
William D Schwieterman President and CEO, Director - [D] [O]	625,747	625,747
Shah Amit B. CHIEF FINANCIAL OFFICER - [O]	358,837	358,837
Vuong Trieu CHAIRMAN AND CEO, Director, 10% Owner - [D] [O] [10%]	93,388,297	93,388,297
Fatih Uckun Chief Medical Officer, 10% Owner - [O] [10%]	2,985,484	2,985,484
Alastair JJ Wood	890
Scott Young Chief Operating Officer - [O]	6,666	6,666

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 OTLC / Oncotelic Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數
2025-07-10	Trieu Vuong	104,000	0.0050	104,000	0.0050	520	730
2025-07-09	Trieu Vuong	1	0.0050	1	0.0050	0
2025-07-08	Trieu Vuong	94,736	0.0050	94,736	0.0050	474
2025-01-31	Trieu Vuong	63,775	0.0280	63,775	0.0280	1,786
2025-01-30	Trieu Vuong	100,003	0.0280	100,003	0.0280	2,800
2025-01-29	Trieu Vuong	183,066	0.0280	183,066	0.0280	5,126
2024-11-22	Trieu Vuong	298,499	0.0289	298,499	0.0289	8,627
2024-08-23	Trieu Vuong	500,000	0.0200	500,000	0.0200	10,000
2023-06-29	Trieu Vuong	425,000	0.0210	425,000	0.0210	8,925

經調整價格已按拆股調整。經調整股數已按拆股調整。

OTLC / Oncotelic Therapeutics, Inc. Insider Trades

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 OTLC / Oncotelic Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士進行過任何未預先計劃的公開市場交易。

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2025-07-10	2025-07-10	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0050	104,000	1		93,293,560
2025-07-10	2025-07-09	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0050	1	0		93,293,561
2025-07-10	2025-07-08	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0050	94,736	0		93,388,297
2025-01-31	2025-01-31	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0280	63,775	2		93,189,560
2025-01-31	2025-01-30	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0280	100,003	3		93,125,785
2025-01-31	2025-01-29	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0280	183,066	5		93,025,782
2024-11-26	2024-11-22	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0289	298,499	9		92,842,716
2024-08-27	2024-08-23	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0200	500,000	10		92,544,217
2023-06-30	2023-06-29	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0210	425,000	9		92,044,217
2023-06-30	2023-06-28	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0260	75,000	2		91,619,217
2023-06-20	2023-06-16	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0260	100,000	3		91,544,217
2023-06-16	2023-06-14	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0326	400,000	13		91,444,217
2023-05-31	2023-05-26	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0341	126,888	4		91,044,217
2023-05-02	2023-05-02	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0450	100,000	4		90,917,329
2022-12-07	2022-12-06	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0500	120,000	6		90,558,021
2022-11-25	2022-11-22	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0800	70,000	6		90,438,021
2022-09-28	2022-09-26	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0680	20,000	1		90,368,021
2022-08-29	2022-08-25	4	Trieu Vuong	OTLC	Common Stock	P - Purchase	D		0.0820	80,000	7		90,348,021
2021-09-08	2021-09-03	4	KING STEVEN W	OTLC	Stock Options	A - Award	D	0.14		500,000		500,000
2021-09-08	2021-09-03	4	Saund Saran	OTLC	Stock Options	A - Award	D	0.14		675,000		675,000
2021-09-08	2021-09-03	4	Trieu Vuong	OTLC	Stock Options	A - Award	D	0.14		225,000		225,000
2021-09-08	2021-09-03	4	MAIDA ANTHONY E III	OTLC	Stock Options	A - Award	D	0.14		600,000		600,000
2021-07-16	2021-07-08	4	Trieu Vuong	OTLC	Stock Options	A - Award	D	0.16		513,953		513,953
2021-07-16	2021-07-08	4	Trieu Vuong	OTLC	Common Stock	A - Award	D			259,302			90,527,323
2021-07-16	2021-03-31	4	Trieu Vuong By Spouse	OTLC	Series A Convertible Preferred Stock	C - Conversion	I			-5,672		0
2021-07-16	2021-03-31	4	Trieu Vuong By Autotelic, Inc.	OTLC	Series A Convertible Preferred Stock	C - Conversion	I			-13,849		0
2021-07-16	2021-03-31	4	Trieu Vuong	OTLC	Series A Convertible Preferred Stock	C - Conversion	D			-74,456		0
2021-07-16	2021-03-31	4	Trieu Vuong By Spouse	OTLC	Common Stock	C - Conversion	I			5,672,025			6,872,529
2021-07-16	2021-03-31	4	Trieu Vuong By Autotelic, Inc.	OTLC	Common Stock	C - Conversion	I			13,849,161			16,780,384
2021-07-16	2021-03-31	4	Trieu Vuong	OTLC	Common Stock	C - Conversion	D			74,455,719			90,268,021
2021-07-16	2021-07-08	4	MAIDA ANTHONY E III	OTLC	Stock Options	A - Award	D	0.16		400,000		400,000
2021-07-16	2021-03-31	4	MAIDA ANTHONY E III	OTLC	Series A Convertible Preferred Stock	C - Conversion	D			-938		0
2021-07-16	2021-03-31	4	MAIDA ANTHONY E III	OTLC	Common Stock	C - Conversion	D			938,646			1,137,314
2021-07-16	2021-07-08	4	Shah Amit B.	OTLC	Stock Options	A - Award	D	0.16		698,256		698,256
2021-07-16	2021-07-08	4	Shah Amit B.	OTLC	Common Stock	A - Award	D			298,837			358,837
2021-07-16	2021-07-08	4	KING STEVEN W	OTLC	Stock Options	A - Award	D	0.16		357,412		357,412
2021-07-16	2021-03-31	4	KING STEVEN W By Artius Bioconsulting	OTLC	Series A Convertible Preferred Stock	C - Conversion	I			-3,292		0
2021-07-16	2021-03-31	4	KING STEVEN W By Artius Bioconsulting	OTLC	Common Stock	C - Conversion	I			3,291,720			3,330,647
2021-07-16	2021-07-08	4	Diamond David	OTLC	Stock Options	A - Award	D	0.16		451,467		451,467
2021-07-16	2021-07-08	4	Saund Saran	OTLC	Stock Options	A - Award	D	0.16		216,279		216,279
2021-07-16	2021-07-08	4	Saund Saran	OTLC	Common Stock	A - Award	D			102,519			16,457,480
2021-07-16	2021-03-31	4	Saund Saran	OTLC	Series A Convertible Preferred Stock	C - Conversion	D			-16,355		0
2021-07-16	2021-03-31	4	Saund Saran	OTLC	Common Stock	C - Conversion	D			16,354,961			16,354,961
2020-11-24	2020-11-24	4	Shah Amit B.	MATN	Common Stock	P - Purchase	D		0.1900	8,220	2		60,000
2020-11-24	2020-11-23	4	Shah Amit B.	MATN	Common Stock	P - Purchase	D		0.1900	20,088	4		51,780
2020-11-24	2020-11-20	4	Shah Amit B.	MATN	Common Stock	P - Purchase	D		0.1950	31,692	6		31,692
2020-11-23	2020-11-19	4	Trieu Vuong	MATN	Common Stock	P - Purchase	D		0.1900	50,500	10		15,812,308
2020-11-23	2020-11-19	4	Park Chulho	MATN	Common Stock	P - Purchase	D		0.1848	22,173	4		2,833,992
2020-05-21		3	KING STEVEN W	MATN	Common Stock		D						1,393,408
2020-05-21		3	KING STEVEN W	MATN	Common Stock		D						1,393,408
2020-05-21		3	KING STEVEN W	MATN	Common Stock		D						1,393,408
2020-05-21		3	MAIDA ANTHONY E III	MATN	Common Stock		D						397,336
2020-05-21		3	MAIDA ANTHONY E III	MATN	Common Stock		D						397,336
2020-05-21		3	MAIDA ANTHONY E III	MATN	Common Stock		D						397,336
2020-03-27	2020-03-26	4	Trieu Vuong	MATN	Common Stock	P - Purchase	D		0.1200	3,000	0		15,761,808
2019-05-02		3	Trieu Vuong	MATN	Common Stock		D						35,649,343
2019-05-02		3	Trieu Vuong By spouse	MATN	Common Stock		I						21,091,039
2019-05-02		3	Trieu Vuong By Autotelic, Inc.	MATN	Common Stock		I						22,821,758
2019-05-02		3	Trieu Vuong	MATN	Common Stock		D						35,649,343
2019-05-02		3	Trieu Vuong By spouse	MATN	Common Stock		I						21,091,039
2019-05-02		3	Trieu Vuong By spouse	MATN	Common Stock		I						21,091,039
2019-05-02		3	Trieu Vuong By Autotelic, Inc.	MATN	Common Stock		I						22,821,758
2019-05-02		3	Trieu Vuong By Autotelic, Inc.	MATN	Common Stock		I						22,821,758
2019-05-02		3	Trieu Vuong	MATN	Common Stock		D						35,649,343
2019-05-02		3	Uckun Fatih	MATN	Common Stock		D						2,985,484
2019-05-02		3	Uckun Fatih	MATN	Common Stock		D						2,985,484
2019-05-02		3	Uckun Fatih	MATN	Common Stock		D						2,985,484
2019-05-02		3	Hsiao Chao	MATN	Common Stock		D						5,974,152
2019-05-02		3	Hsiao Chao	MATN	Common Stock		D						5,974,152
2019-05-02		3	Hsiao Chao	MATN	Common Stock		D						5,974,152
2019-05-02		3	Park Chulho	MATN	Common Stock		D						5,623,638
2019-05-02		3	Park Chulho	MATN	Common Stock		D						5,623,638
2019-05-02		3	Park Chulho	MATN	Common Stock		D						5,623,638
2019-05-02		3	Hwang Larn	MATN	Common Stock		D						8,191,162
2019-05-02		3	Hwang Larn	MATN	Common Stock		D						8,191,162
2019-05-02		3	Hwang Larn	MATN	Common Stock		D						8,191,162
2018-06-22	2018-06-20	4	SANDAGE BOBBY W PHD	MATN	Stock Option (Right to Buy)	A - Award	D	0.22		258,171		258,171
2018-06-22	2018-06-20	4	Schwieterman William D	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.22		500,000		500,000
2018-06-22	2018-06-20	4	Schwieterman William D	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.22		500,000		500,000
2018-06-22	2018-06-20	4	CHAPLIN DAVID	MATN	Stock Option (Right to Buy)	A - Award	D	0.22		258,171		258,171
2018-06-22	2018-06-20	4	LOAR MATTHEW M	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.22		500,000		500,000
2018-06-22	2018-06-20	4	LOAR MATTHEW M	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.22		250,000		250,000
2018-06-22	2018-06-20	4	Pedder Simon	MATN	Stock Option (Right to Buy)	A - Award	D	0.22		258,171		258,171
2018-06-22	2018-06-20	4	Reynolds Donald Rogers	MATN	Stock Option (Right to Buy)	A - Award	D	0.22		258,171		258,171
2018-04-16	2018-04-12	4	Schwieterman William D	MATN	Common Stock B Warrant (Right to Buy)	P - Purchase	D	0.40		312,500		312,500
2018-04-16	2018-04-12	4	Schwieterman William D	MATN	Common Stock A Warrant (Right to Buy)	P - Purchase	D	0.40		312,500		312,500
2018-04-16	2018-04-12	4	Schwieterman William D	MATN	Common Stock	P - Purchase	D			625,000			625,747
2018-04-16	2018-04-12	4	Reynolds Donald Rogers	MATN	Common Stock B Warrants (Right to Buy)	P - Purchase	D	0.40		125,000		125,000
2018-04-16	2018-04-12	4	Reynolds Donald Rogers	MATN	Common Stock A Warrants (Right to Buy)	P - Purchase	D	0.40		125,000		125,000
2018-04-16	2018-04-12	4	Reynolds Donald Rogers	MATN	Common Stock	P - Purchase	D			250,000			280,000
2018-04-16	2018-04-12	4	LOAR MATTHEW M	MATN	Common Stock A Warrant (Right to Buy)	P - Purchase	D	0.40		125,000		125,000
2018-04-16	2018-04-12	4	LOAR MATTHEW M	MATN	Common Stock B Warrant (Right to Buy)	P - Purchase	D	0.40		125,000		125,000
2018-04-16	2018-04-12	4	LOAR MATTHEW M	MATN	Common Stock	P - Purchase	D			250,000			300,000
2017-06-12	2017-06-09	4	Reynolds Donald Rogers	MATN	Stock Option (Right to Buy)	A - Award	D	0.51		121,483		121,483
2017-06-12	2017-06-09	4	SANDAGE BOBBY W PHD	MATN	Stock Option (Right to Buy)	A - Award	D	0.51		121,483		121,483
2017-06-12	2017-06-09	4	Pedder Simon	MATN	Stock Option (Right to Buy)	A - Award	D	0.51		121,483		121,483
2017-01-13	2017-01-12	4	CHAPLIN DAVID	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.38	0.3750	262,500	98	262,500
2017-01-13	2017-01-12	4	LOAR MATTHEW M	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.38	0.3750	350,000	131	350,000
2017-01-13	2017-01-12	4	Schwieterman William D	MATN	Employee Stock Option (Right to Buy)	A - Award	D	0.38	0.3750	550,000	206	550,000
2016-12-20	2016-12-16	4	Reynolds Donald Rogers	MATN	Common Stock, $.01 par value per share	P - Purchase	D		0.3550	9,950	4		30,000
2016-12-20	2016-12-16	4	Reynolds Donald Rogers	MATN	Common Stock, $.01 par value per share	P - Purchase	D		0.3500	7,350	3		20,050
2016-12-20	2016-12-16	4	Reynolds Donald Rogers	MATN	Common Stock, $.01 par value per share	P - Purchase	D		0.3400	12,700	4		12,700
2016-10-27	2016-10-25	4	Reynolds Donald Rogers	MATN	Stock Option (Right to Buy)	A - Award	D	0.58		135,612		135,612
2016-10-27	2016-10-25	4	SANDAGE BOBBY W PHD	MATN	Stock Option (Right to Buy)	A - Award	D	0.58		135,612		135,612
2016-06-03	2016-06-01	4	DRISCOLL FREDERICK W	OXGN	Stock Option (Right to Buy)	A - Award	D	0.65		91,564		91,564
2016-06-03	2016-06-01	4	McMahon Gerald PhD	OXGN	Stock Option (Right to Purchase)	A - Award	D	0.65		91,564		91,564
2016-06-03	2016-06-01	4	Pedder Simon	OXGN	Stock Option (Right to Buy)	A - Award	D	0.65		91,564		91,564
2016-04-19	2016-03-21	4/A	Schwieterman William D	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	0.73		500,000		500,000
2016-03-23	2016-03-21	4	Pedder Simon	OXGN	Stock Option (Right to Buy)	A - Award	D	0.73		99,711		99,711
2016-03-23	2016-03-21	4	LOAR MATTHEW M	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	0.73		262,500		262,500
2016-03-23	2016-03-21	4	Schwieterman William D	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	0.73		525,000		525,000
2016-03-23	2016-03-21	4	CHAPLIN DAVID	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	0.73		262,500		262,500
2015-07-20		3	LOAR MATTHEW M	OXGN	Common Stock		D						100,000
2015-07-20		3	LOAR MATTHEW M	OXGN	Common Stock		D						100,000
2015-07-20	2015-07-20	4	LOAR MATTHEW M	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	1.37		150,000		150,000
2015-05-29	2015-05-28	4	CHAPLIN DAVID	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	1.43		225,000		225,000
2015-05-29	2015-05-28	4	DRISCOLL FREDERICK W	OXGN	Stock Option (Right to Buy)	A - Award	D	1.43		77,996		77,996
2015-05-29	2015-05-28	4	McMahon Gerald PhD	OXGN	Stock Option (Right to Purchase)	A - Award	D	1.43		77,996		77,996
2015-05-29	2015-05-28	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	1.43		77,996		77,996
2015-05-29	2015-05-28	4	Schwieterman William D	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	1.43		300,000		300,000
2015-05-29	2015-05-28	4	Schwieterman William D	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	1.43		75,000		75,000
2015-05-29	2015-05-28	4	RICHING BARBARA	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	1.43		150,000		150,000
2014-07-07	2014-07-02	4	DRISCOLL FREDERICK W	OXGN	Stock Option (Right to Buy)	A - Award	D	2.60		7,920		7,920
2014-07-07	2014-07-02	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.60		5,280		5,280
2014-07-07	2014-07-02	4	McMahon Gerald PhD	OXGN	Common Stock, $0.01 par value per share	A - Award	D			3,847			18,611
2014-07-07	2014-07-02	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.60		5,280		5,280
2014-05-30	2014-05-30	4	RICHING BARBARA	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	2.66		75,000		75,000
2014-05-19	2014-05-15	4	CHAPLIN DAVID	OXGN	Employee Stock Option (Right to Buy)	A - Award	D	2.95		150,000		150,000
2014-01-06		3	DRISCOLL FREDERICK W	OXGN	No securities are beneficially owned.		D						0
2014-01-06	2014-01-02	4	DRISCOLL FREDERICK W	OXGN	Stock Option (Right to Buy)	A - Award	D	2.79		30,000		30,000
2014-01-06	2014-01-02	4	DRISCOLL FREDERICK W	OXGN	Stock Option (Right to Buy)	A - Award	D	2.79		7,310		7,310
2014-01-06	2014-01-02	4	CHAPLIN DAVID	OXGN	Stock Option (Right to Buy)	A - Award	D	2.79		4,880		4,880
2014-01-06	2014-01-02	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.79		4,880		4,880
2014-01-06	2014-01-02	4	McMahon Gerald PhD	OXGN	Common Stock, $0.01 par value per share	A - Award	D			3,584			14,764
2014-01-06	2014-01-02	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.79		4,880		4,880
2013-08-09	2013-08-08	4	LANGECKER PETER	OXGN	Common Stock, $0.01 par value per share	A - Award	D			72,993			77,993
2013-07-02	2013-07-01	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.70		5,030		5,030
2013-07-02	2013-07-01	4	HOWSON TAMAR D	OXGN	Common Stock, $0.01 par value per share	A - Award	D			3,703			8,761
2013-07-02	2013-07-01	4	McMahon Gerald PhD	OXGN	Common Stock, $0.01 par value per share	A - Award	D			7,407			11,180
2013-07-02	2013-07-01	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	2.70		10,060		10,060
2013-07-02	2013-07-01	4	CHAPLIN DAVID	OXGN	Stock Option (Right to Buy)	A - Award	D	2.70		10,060		10,060
2013-07-02	2013-07-01	4	Wood Alastair JJ	OXGN	Stock Option (Right to Buy)	A - Award	D	2.70		890		890
2013-07-01	2013-06-28	4	LANGECKER PETER	OXGN	Common Stock, par value $0.01 per share	P - Purchase	D		2.7500	3,000	8		5,000
2013-06-26	2013-06-25	4	LANGECKER PETER	OXGN	Common Stock, par value $0.01 per share	P - Purchase	D		2.7860	2,000	6		2,000
2013-02-28	2013-02-27	4	LANGECKER PETER	OXGN	Stock Option (Right to Buy)	A - Award	D	4.18		8,333		8,333
2013-02-28	2013-02-27	4	RICHING BARBARA	OXGN	Stock Option (Right to Buy)	A - Award	D	4.18		15,000		15,000
2013-01-24		3	CHAPLIN DAVID	OXGN	Common Stock, $0.01 par value per share		D						1,006
2013-01-24	2013-01-23	4	CHAPLIN DAVID	OXGN	Stock Option (Right to Buy)	A - Award	D	4.36		6,260		6,260
2013-01-03	2013-01-02	4	Wood Alastair JJ	OXGN	Stock Option (Right to Buy)	A - Award	D	5.30		5,140		5,140
2013-01-03	2013-01-02	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	5.30		5,140		5,140
2013-01-03	2013-01-02	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	5.30		2,570		2,570
2013-01-03	2013-01-02	4	HOWSON TAMAR D	OXGN	Common Stock, $0.01 par value per share	A - Award	D			1,886			5,058
2013-01-03	2013-01-02	4	McMahon Gerald PhD	OXGN	Common Stock, $0.01 par value per share	A - Award	D			3,773			3,773
2012-08-01	2012-07-30	4	LANGECKER PETER	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		100,000		100,000
2012-07-05	2012-07-01	4/A	Wood Alastair JJ	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-05	2012-07-01	4/A	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-05	2012-07-01	4/A	McMahon Gerald PhD	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-05	2012-07-01	4/A	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		25,200		25,200
2012-07-05	2012-07-01	4/A	HOWSON TAMAR D	OXGN	Common Stock, $0.01 par value per share	A - Award	D			18,148			38,060
2012-07-03	2012-07-02	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-03	2012-07-02	4	McMahon Gerald PhD	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-03	2012-07-02	4	Wood Alastair JJ	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		50,500		50,500
2012-07-03	2012-07-02	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.55		25,200		25,200
2012-07-03	2012-07-02	4	HOWSON TAMAR D	OXGN	Common Stock, $0.01 par value per share	A - Award	D			18,148			38,060
2012-01-04	2012-01-02	4	HOWSON TAMAR D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.99		14,200		14,200
2012-01-04	2012-01-02	4	HOWSON TAMAR D	OXGN	Common Stock, $0.01 par value per share	A - Award	D			10,101			19,912
2012-01-04	2012-01-02	4	McMahon Gerald PhD	OXGN	Stock Option (Right to Buy)	A - Award	D	0.99		28,300		28,300
2012-01-04	2012-01-02	4	Wood Alastair JJ	OXGN	Stock Option (Right to Buy)	A - Award	D	0.99		28,300		28,300
2012-01-04	2012-01-02	4	Schwieterman William D	OXGN	Stock Option (Right to Buy)	A - Award	D	0.99		28,300		28,300
2008-10-31		3	KESSEL MARK	OXGN	Common Stock, par value $0.01 per share		I						5,835,241
2005-08-30	2005-08-24	4	Chin Richard	OXGN	Common Stock	A - Award	D			40,000			40,000
2005-07-19	2005-07-15	4	DRISCOLL FREDERICK W	OXGN	Common Stock	A - Award	D			80,000			122,000
2005-07-19	2005-07-15	4	CHAPLIN DAVID	OXGN	Common Stock	A - Award	D			80,000			131,100
2004-09-02	2004-07-28	4	SODERBERG PER OLOF	OXGN	Options to purchase Common Stock	A - Award	D	5.03		10,000		10,000
2004-09-02	2004-07-28	4	SHIEBLER WILLIAM N	OXGN	Options to purchase Common Stock	A - Award	D	5.03		10,000		10,000
2004-09-02	2004-07-28	4	LAFFER ARTHUR B	OXGN	Options to purchase Common Stock	A - Award	D	5.03		10,000		10,000
2004-09-02	2004-07-28	4	CITRON JOEL TOMAS	OXGN	Options to purchase Common Stock	A - Award	D	5.03		25,000		25,000
2004-03-19		3	YOUNG SCOTT	OXGN	Restricted common stock		D						6,666
2004-02-11	2003-11-24	5	SODERBERG PER OLOF	OXGN	Common Stock	J - Other	D			-49,144			179,256

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

OTLC / Oncotelic Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5